Literature DB >> 20722488

The role of exposure reconstruction in occupational human health risk assessment: current methods and a recommended framework.

Jennifer Sahmel1, Kathryn Devlin, Dennis Paustenbach, Dana Hollins, Shannon Gaffney.   

Abstract

Exposure reconstruction for substances of interest to human health is a process that has been used, with various levels of sophistication, as far back as the 1930s. The importance of robust and high-quality exposure reconstruction has been recognized by many researchers. It has been noted that misclassification of reconstructed exposures is relatively common and can result in potentially significant effects on the conclusions of a human health risk assessment or epidemiology study. In this analysis, a review of the key exposure reconstruction approaches described in over 400 papers in the peer-reviewed literature is presented. These approaches have been critically evaluated and classified according to quantitative, semiquantitative, and qualitative approaches. Our analysis indicates that much can still be done to improve the overall quality and consistency of exposure reconstructions and that a systematic framework would help to standardize the exposure reconstruction process in the future. The seven recommended steps in the exposure reconstruction process include identifying the goals of the reconstruction, organizing and ranking the available data, identifying key data gaps, selecting the best information sources and methodology for the reconstruction, incorporating probabilistic methods into the reconstruction, conducting an uncertainty analysis, and validating the results of the reconstruction. Influential emerging techniques, such as Bayesian data analysis, are highlighted. Important issues that will likely influence the conduct of exposure reconstruction into the future include improving statistical analysis methods, addressing the issue of chemical mixtures, evaluating aggregate exposures, and ensuring transparency with respect to variability and uncertainty in the reconstruction effort.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722488     DOI: 10.3109/10408444.2010.501052

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  5 in total

1.  Integration of gene chip and topological network techniques to screen a candidate biomarker gene (CBG) for predication of the source water carcinogenesis risks on mouse Mus musculus.

Authors:  Jie Sun; Shupei Cheng; Aimin Li; Rui Zhang; Bing Wu; Yan Zhang; Xuxiang Zhang
Journal:  Ecotoxicology       Date:  2011-05-04       Impact factor: 2.823

2.  The application of global sensitivity analysis in the development of a physiologically based pharmacokinetic model for m-xylene and ethanol co-exposure in humans.

Authors:  George D Loizou; Kevin McNally; Kate Jones; John Cocker
Journal:  Front Pharmacol       Date:  2015-06-30       Impact factor: 5.810

3.  Reconstructing Historical VOC Concentrations in Drinking Water for Epidemiological Studies at a U.S. Military Base: Summary of Results.

Authors:  Morris L Maslia; Mustafa M Aral; Perri Z Ruckart; Frank J Bove
Journal:  Water (Basel)       Date:  2016-10-13       Impact factor: 3.103

Review 4.  Evaluating the Theoretical Background of STOFFENMANAGER® and the Advanced REACH Tool.

Authors:  Antti Joonas Koivisto; Michael Jayjock; Kaarle J Hämeri; Markku Kulmala; Patrick Van Sprang; Mingzhou Yu; Brandon E Boor; Tareq Hussein; Ismo K Koponen; Jakob Löndahl; Lidia Morawska; John C Little; Susan Arnold
Journal:  Ann Work Expo Health       Date:  2022-04-22       Impact factor: 2.779

5.  Asbestos Exposure in Patients with Malignant Pleural Mesothelioma included in the PRIMATE Study, Lombardy, Italy.

Authors:  Andrea Spinazzè; Dario Consonni; Francesca Borghi; Sabrina Rovelli; Andrea Cattaneo; Carolina Zellino; Barbara Dallari; Angela Cecilia Pesatori; Hans Kromhout; Susan Peters; Luciano Riboldi; Domenico Maria Cavallo; Carolina Mensi
Journal:  Int J Environ Res Public Health       Date:  2022-03-13       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.